BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17353783)

  • 21. Acute cell-mediated rejection in orthotopic pig-to-mouse corneal xenotransplantation.
    Oh JY; Kim MK; Ko JH; Lee HJ; Kim Y; Park CS; Park CG; Kim SJ; Wee WR; Lee JH
    Xenotransplantation; 2009; 16(2):74-82. PubMed ID: 19392722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
    Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phylogenetic disparity influences the predominance of direct over indirect pathway of antigen presentation in islet xenotransplantation.
    Andres A; Toso C; Morel P; Bosco D; Bucher P; Oberholzer J; Mathe Z; Mai G; Wekerle T; Berney T; Bühler LH
    Transplant Proc; 2005; 37(1):463-5. PubMed ID: 15808677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
    Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of rat islet xenograft survival in the liver of IFN-gamma-deficient mice.
    Maki T; Yasunami Y; Ikehara Y; Kodama S; Nakano M; Nakayama T; Taniguchi M; Ikeda S
    J Surg Res; 2000 Sep; 93(1):101-7. PubMed ID: 10945950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses.
    Lin Y; Vandeputte M; Waer M
    J Immunol; 1997 Jun; 158(12):5658-67. PubMed ID: 9190914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1.
    Gersuk GM; Razai LW; Marr KA
    J Immunol Methods; 2008 Jan; 329(1-2):157-66. PubMed ID: 17997408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
    Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of islet Toll-like receptors in pig to mouse islet xenotransplantation.
    Ro H; Lee EW; Hong JH; Han KH; Yeom HJ; Kim HJ; Kim MG; Jung HS; Oh KH; Park KS; Ahn C; Yang J
    Cell Transplant; 2013; 22(9):1709-22. PubMed ID: 23051007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival and function of intraportal porcine and human islet xenografts in nondiabetic nude mice.
    Xu BY; Yu Y; Al-Abdullah IH; Kandeel F; Hering B; Wright JR
    Transplant Proc; 2008 Mar; 40(2):584-6. PubMed ID: 18374135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanism of rejection of islet of Langerhans xenografts].
    Bühler L; Deng S; Andereggen E; Bubloz C; Mage R; Mentha G; Morel P
    Swiss Surg; 1995; (4):210-3. PubMed ID: 9156823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection.
    McKay D; Shigeoka A; Rubinstein M; Surh C; Sprent J
    Eur J Immunol; 2006 Aug; 36(8):1994-2002. PubMed ID: 16874736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway.
    Olack BJ; Jaramillo A; Benshoff ND; Kaleem Z; Swanson CJ; Lowell JA; Mohanakumar T
    Xenotransplantation; 2002 Nov; 9(6):393-401. PubMed ID: 12371935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation.
    Sigrist S; Ebel N; Langlois A; Bosco D; Toso C; Kleiss C; Mandes K; Berney T; Pinget M; Belcourt A; Kessler L
    Transplant Proc; 2005 Oct; 37(8):3516-8. PubMed ID: 16298647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.